Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Human Blood Cells for the Identification of Early Biomarkers of Cognitive Damage

NCT05582941 is registered in ClinicalTrials.gov with University of the Balearic Islands as lead sponsor.

NCT NCT05582941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05582941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Human Blood Cells for the Identification of Early Biomarkers of Cognitive Damage
Lead sponsor
University of the Balearic Islands
Phase
Observational
Overall status
Completed
Start date
April 1, 2022
Completion date
May 31, 2023
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia due to alzheimer's disease (disorder), mild cognitive impairment due to alzheimer's disease